BioRestorative Therapies Cash from Financing (TTM) Insights

BioRestorative Therapies Inc (BRTX)

1.46 +0.09 (+6.57%) USD | NASDAQ | May 02, 16:00

1.37 -0.09 (-6.16%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
December 31, 2023	2.351M
September 30, 2023	2.266M
June 30, 2023	0.4117M
March 31, 2023	0.00
December 31, 2022	0.00
September 30, 2022	21.07M
June 30, 2022	21.07M
March 31, 2022	21.07M
December 31, 2021	21.32M
September 30, 2021	3.711M
June 30, 2021	4.112M
March 31, 2021	4.825M
December 31, 2020	5.027M
September 30, 2020	3.281M
June 30, 2020	3.411M
March 31, 2020	4.931M
December 31, 2019	6.838M
September 30, 2019	6.689M
June 30, 2019	7.613M
March 31, 2019	6.427M
December 31, 2018	4.783M
September 30, 2018	5.032M
June 30, 2018	4.086M
March 31, 2018	3.796M
December 31, 2017	4.277M

Date	Value
September 30, 2017	3.557M
June 30, 2017	3.776M
March 31, 2017	4.258M
December 31, 2016	5.057M
September 30, 2016	5.218M
June 30, 2016	5.290M
March 31, 2016	4.778M
December 31, 2015	3.680M
September 30, 2015	2.943M
June 30, 2015	3.295M
March 31, 2015	3.467M
December 31, 2014	3.286M
September 30, 2014	3.742M
June 30, 2014	3.027M
March 31, 2014	2.329M
December 31, 2013	2.884M
September 30, 2013	2.888M
June 30, 2013	2.995M
March 31, 2013	5.06M
December 31, 2012	4.116M
September 30, 2012	4.309M
June 30, 2012	4.017M
March 31, 2012	1.831M
December 31, 2011	2.850M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Dec 2022

21.32M

Maximum

Dec 2021

7.369M

Average

4.825M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks